AI-enabled medical devices sales will rise through 2036, driven by software at 51.2% of the component outlook segment in 2026. The market was valued at USD 18.90 billion in 2025 and is expected to be worth USD 679.84 billion by 2036, creating an incremental opportunity of USD 653.66 billion.